(Q39167383)

9 September 2017

Bruton's tyrosine kinase: potential target in human multiple myeloma (English)

1 reference

9 September 2017

Ying Liu

1

1 reference

9 September 2017

Ying Dong

2

1 reference

9 September 2017

Qian-Li Jiang

3

1 reference

9 September 2017

Bo Zhang

4

1 reference

9 September 2017

An-Mei Hu

5

1 reference

9 September 2017

15 May 2013

1 reference

9 September 2017

1 reference

9 September 2017

55

1 reference

9 September 2017

177-181

1 reference

9 September 2017

1

1 reference

Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium

9 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Heparanase enhances the insulin receptor signaling pathway to activate extracellular signal-regulated kinase in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Activation of tyrosine kinases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

The Src, Syk, and Tec family kinases: distinct types of molecular switches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

The role of Tec family kinases in myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Absence of Tec family kinases interleukin-2 inducible T cell kinase (Itk) and Bruton's tyrosine kinase (Btk) severely impairs Fc epsilonRI-dependent mast cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Bruton's tyrosine kinase: oncotarget in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Small compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

Structure-based design of novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.794458

10.3109/10428194.2013.794458

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference